Total Funding
14
Total FundingSeed raised
Growth Score in past quarter
pts
Heat Score 14 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Selexagen Therapeutics operates as a pharmaceutical company that develops targeted therapies for cancer.
Randall E Woods: Founder and Chairman of the BoardPast Role: Sophiris Bio, Director, President and CEO
Patrick O’Connor: Founder, CSOPast Role: Ardea Biosciences, Contributed to the Oncology Programs
About the Company
Selexagen Therapeutics, Inc. operates as a pharmaceutical company and develops targeted therapies for cancer. The company was incorporated in 2008 and is based in San Diego, California.
Women Founded
Women Led
